Françoise Labrousse and Renaud Bonnet co-lead the team at Jones Day, which often advises on collaboration and investment agreements. Labrousse is recommended for her deep knowledge of administrative disputes, while private equity specialist Bonnet often assists with M&A, IPOs, and the full spectrum of financing issues. Described by clients as ‘one of the foremost patent litigators in France’, Thomas Bouvet is well equipped to advise on SPCs, standard essential patents, and patent enforcement actions relating to medical devices and pharma products.
L’éditorial du Legal 500
- Profil
- Réseaux sociaux
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘Thomas Bouvet has an excellent team for life sciences/pharma patent litigation.’
‘Thomas Bouvet - one of the foremost patent litigators in France. Colin Devinant - a rising star in Thomas' excellent team.’
‘Very competent specialised team, which has real expertise on the market. Very well trained lawyers. Large volume of deals.’
‘Renaud Bonnet is a seasoned specialist who knows his clients well, has been supporting them for a long time and knows how to adapt to all their issues.’
Clients clés
- Institut Pasteur
- Schwind eye-tech-solutions
- Progelife
- bioMérieux
- Nanobiotix
- Cellectis
- ADOCIA
- Mauna Kea Technologies
- Sofinnova and NVentures
- Therapixel
Avocats
Responsable de la pratique
Françoise Labrousse; Renaud Bonnet
Autres avocats clés
Thomas Bouvet; Colin Devinant